|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,423.98 CNY | -0.36% |
|
-1.74% | -6.56% |
| 11-28 | Kweichow Moutai's board elects Chen Hua as chairman | RE |
| 11-25 | Declaration of Voting Results by Shanghai Wankexin Biotechnology | CI |
| Capitalization | 1,783B 252B 216B 202B 189B 352B 22,651B 381B 2,372B 915B 10,703B 946B 926B 39,026B | P/E ratio 2025 * |
19.6x | P/E ratio 2026 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise value | 1,580B 223B 192B 179B 167B 312B 20,074B 338B 2,103B 811B 9,486B 839B 821B 34,586B | EV / Sales 2025 * |
8.63x | EV / Sales 2026 * | 7.85x |
| Free-Float |
38.35% | Yield 2025 * |
3.94% | Yield 2026 * | 4.19% |
| 1 day | -0.36% | ||
| 1 week | -1.74% | ||
| Current month | -1.83% | ||
| 1 month | -0.77% | ||
| 3 months | -3.82% | ||
| 6 months | -5.63% | ||
| Current year | -6.56% |
| 1 week | 1,418.38 |  | 1,462.27 |
| 1 month | 1,418.38 | | 1,486.07 |
| Current year | 1,400 | | 1,657.99 |
| 1 year | 1,400 | | 1,657.99 |
| 3 years | 1,245.83 | | 1,935 |
| 5 years | 1,245.83 | | 2,627.88 |
| 10 years | 195.51 | | 2,627.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Li Wang
CEO | Chief Executive Officer | 53 | 2023-08-18 |
Jiang Yan
DFI | Director of Finance/CFO | 48 | 2021-11-14 |
Cong Ying Cai
AUD | Comptroller/Controller/Auditor | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ya Lin You
CHM | Chairman | 56 | 2020-03-19 |
Tian Yong Guo
BRD | Director/Board Member | 56 | 2022-06-15 |
Shi Zhong Liu
BRD | Director/Board Member | 50 | 2022-06-15 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.36% | -1.74% | -6.73% | -12.85% | 253B | |
| -0.99% | -3.22% | -22.14% | -29.81% | 63.52B | |
| -3.42% | -6.27% | -9.48% | -30.84% | 32.4B | |
| -3.76% | -5.35% | -7.58% | -33.75% | 27.65B | |
| -1.69% | -5.76% | -27.86% | -57.21% | 13.52B | |
| +0.75% | -1.89% | -7.20% | +53.00% | 11.19B | |
| -1.61% | -5.89% | -18.26% | -35.62% | 10.58B | |
| -1.33% | +2.84% | -0.69% | -43.57% | 8.23B | |
| -1.92% | -4.61% | -23.67% | -16.79% | 6.51B | |
| -0.89% | -5.16% | -34.70% | -20.86% | 4.56B | |
| Average | -1.52% | -3.83% | -15.83% | -22.83% | 43.15B | |
| Weighted average by Cap. | -0.99% | -2.86% | -10.65% | -19.01% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 183B 25.91B 22.21B 20.77B 19.4B 36.13B 2,327B 39.13B 244B 94.04B 1,100B 97.23B 95.16B 4,009B | 198B 28.06B 24.06B 22.5B 21.01B 39.12B 2,520B 42.38B 264B 102B 1,191B 105B 103B 4,342B |
| Net income | 91.06B 12.88B 11.04B 10.33B 9.64B 17.96B 1,157B 19.45B 121B 46.75B 547B 48.33B 47.3B 1,993B | 98.48B 13.93B 11.94B 11.17B 10.43B 19.42B 1,251B 21.04B 131B 50.56B 591B 52.27B 51.16B 2,155B |
| Net Debt | -203B -28.69B -24.6B -23B -21.48B -40B -2,577B -43.33B -270B -104B -1,218B -108B -105B -4,439B | -226B -31.93B -27.38B -25.61B -23.92B -44.53B -2,868B -48.24B -300B -116B -1,355B -120B -117B -4,942B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-03 | 1,423.98 ¥ | -0.36% | 2,907,539 |
| 25-12-03 | 1,429.10 ¥ | -0.48% | 2,357,279 |
| 25-12-02 | 1,436.03 ¥ | -0.83% | 2,504,726 |
| 25-12-01 | 1,448.00 ¥ | -0.17% | 2,733,342 |
| 25-11-28 | 1,450.50 ¥ | +0.22% | 2,321,121 |
End-of-day quote Shanghai S.E., December 03, 2025
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 600519 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition